|
|
Article: New Study Minimizes Concerns about PGD's Impact on Embryos and Offers Encouraging Data on Implantation Success Rates; Lawrence Werlin Presents New Study at Pacific Coast Reproductive Society's Annual Conference.
- Article from:
- Business Wire
- Article date:
- May 3, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif. -- At the Pacific Coast Reproductive Society's (PCRS) Annual Conference, Dr. Lawrence B. Werlin will present groundbreaking discoveries from his research on the effects of Preimplantation Genetic Diagnosis (PGD) on embryos. The conference, May 4-8, 2005, in Indian Wells, Calif., brings together leaders in the field of reproductive medicine throughout North America and abroad.
PGD is a therapeutic and genetic testing tool that allows for the analysis and transfer of healthy embryos back to the uterus. Over the years, PGD has gained greater recognition for its ability to analyze the cells of a developing embryo via biopsy for genetic and chromosomal ...